Association Between the RAD51 135 G>C Polymorphism and Risk of Cancer: a Meta-analysis of 19,068 Cases and 22,630 Controls

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Sep 17

PMID 24040396

Citations 11

Authors

Wei Wang

Jia-Lin Li

Xiao-Feng He

An-Ping Li

Yong-Lin Cai

Na Xu

Shu-Mei Sun

Bing-Yi Wu

Affiliations

Soon will be listed here.

Abstract

Background: RAD51 135G>C can modify promoter activity and the penetrance of BRCA1/2 mutations, which plays vital roles in the etiology of various cancer. To date, previous published data on the association between RAD51 135G>C polymorphism and cancer risk remained controversial. Recent meta-analysis only analyzed RAD51 135G>C polymorphism with breast cancer risk, but the results were also inconsistent.

Methods: A meta-analysis based on 39 case-control studies was performed to investigate the association between cancer susceptibility and RAD51 135G>C. Odds ratios (OR) with 95% confidence intervals (CIs) were used to assess the association in different inheritance models. Heterogeneity among studies was tested and sensitivity analysis was applied.

Results: Overall, no significant association was found between RAD51 135G>C polymorphism and cancer susceptibility in any genetic model. In further stratified analysis, significantly elevated breast cancer risk was observed in BRCA2 mutation carriers (recessive model: OR = 4.88, 95% CI = 1.10-21.67; additive model: OR = 4.92, 95% CI = 1.11-21.83).

Conclusions: This meta-analysis suggests that RAD51 variant 135C homozygote is associated with elevated breast cancer risk among BRCA2 mutation carriers. Moreover, our work also points out the importance of new studies for RAD51 135G>C association in acute myeloid leukemia, especially in Caucasians, where at least some of the covariates responsible for heterogeneity could be controlled, to obtain a more conclusive understanding about the function of the RAD51 135G>C polymorphism in cancer development.

Citing Articles

The influence of RAD51 (rs1801320) on breast cancer risk: an updated meta-analysis.

Khan N, Alqarni S, Yousuf A, Shehzad I, Khan W, Gu W Discov Oncol. 2025; 16(1):289.

PMID: 40063134 PMC: 11893934. DOI: 10.1007/s12672-025-02012-5.

Meta-analysis of the association between overexpression of RAD51 family genes and prognosis and clinical features in breast cancer.

Liu Y, Shen J Sci Rep. 2025; 15(1):4229.

PMID: 39905235 PMC: 11794475. DOI: 10.1038/s41598-025-88763-1.

, and Polymorphisms as Potential Predictive Biomarkers of Adjuvant Radiotherapy Toxicity in Early HER2-Positive Breast Cancer.

Goricar K, Dugar F, Dolzan V, Marinko T Cancers (Basel). 2022; 14(18).

PMID: 36139526 PMC: 9496855. DOI: 10.3390/cancers14184365.

Homologous recombination DNA repair gene RAD51, XRCC2 & XRCC3 polymorphisms and breast cancer risk in South Indian women.

Rajagopal T, Seshachalam A, Rathnam K, Talluri S, Venkatabalasubramanian S, Rao Dunna N PLoS One. 2022; 17(1):e0259761.

PMID: 35061678 PMC: 8782413. DOI: 10.1371/journal.pone.0259761.

Polymorphism of DNA repair genes in breast cancer.

Smolarz B, Michalska M, Samulak D, Romanowicz H, Wojcik L Oncotarget. 2019; 10(4):527-535.

PMID: 30728902 PMC: 6355183. DOI: 10.18632/oncotarget.26568.

References

Gao L, Pan X, Li L, Liang W, Zhu Y, Zhang L . RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies. Breast Cancer Res Treat. 2010; 125(3):827-35. DOI: 10.1007/s10549-010-0995-8. View

Romanowicz-Makowska H, Smolarz B, Polac I, Sporny S . Single nucleotide polymorphisms of RAD51 G135C, XRCC2 Arg188His and XRCC3 Thr241Met homologous recombination repair genes and the risk of sporadic endometrial cancer in Polish women. J Obstet Gynaecol Res. 2012; 38(6):918-24. DOI: 10.1111/j.1447-0756.2011.01811.x. View

Chanock S . Candidate genes and single nucleotide polymorphisms (SNPs) in the study of human disease. Dis Markers. 2001; 17(2):89-98. PMC: 3850582. DOI: 10.1155/2001/858760. View

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

Baumann P, West S . Role of the human RAD51 protein in homologous recombination and double-stranded-break repair. Trends Biochem Sci. 1998; 23(7):247-51. DOI: 10.1016/s0968-0004(98)01232-8. View

Sliwinski T, Krupa R, Majsterek I, Rykala J, Kolacinska A, Morawiec Z . Polymorphisms of the BRCA2 and RAD51 genes in breast cancer. Breast Cancer Res Treat. 2005; 94(2):105-9. DOI: 10.1007/s10549-005-0672-5. View

Levy-Lahad E, Lahad A, Eisenberg S, Dagan E, Paperna T, Kasinetz L . A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers. Proc Natl Acad Sci U S A. 2001; 98(6):3232-6. PMC: 30636. DOI: 10.1073/pnas.051624098. View

Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, Medeiros R . DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer Res Treat. 2006; 103(2):209-17. DOI: 10.1007/s10549-006-9364-z. View

Wei Q, Cheng L, Amos C, Wang L, Guo Z, Hong W . Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst. 2000; 92(21):1764-72. DOI: 10.1093/jnci/92.21.1764. View

10.

Chang T, Wang S, Guo Y, Tsai P, Huang C, Huang W . Glutathione S-transferase polymorphisms associated with risk of breast cancer in southern Taiwan. Breast. 2006; 15(6):754-61. DOI: 10.1016/j.breast.2006.03.008. View

11.

Stark J, Pierce A, Oh J, Pastink A, Jasin M . Genetic steps of mammalian homologous repair with distinct mutagenic consequences. Mol Cell Biol. 2004; 24(21):9305-16. PMC: 522275. DOI: 10.1128/MCB.24.21.9305-9316.2004. View

12.

Mantel N, Haenszel W . Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22(4):719-48. View

13.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

14.

Vispe S, Cazaux C, Lesca C, Defais M . Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation. Nucleic Acids Res. 1998; 26(12):2859-64. PMC: 147643. DOI: 10.1093/nar/26.12.2859. View

15.

Shinohara A, Ogawa H, Matsuda Y, Ushio N, Ikeo K, Ogawa T . Cloning of human, mouse and fission yeast recombination genes homologous to RAD51 and recA. Nat Genet. 1993; 4(3):239-43. DOI: 10.1038/ng0793-239. View

16.

Sobti R, Kaur S, Sharma V, Singh S, Hosseini S, Kler R . Susceptibility of XPD and RAD51 genetic variants to carcinoma of urinary bladder in North Indian population. DNA Cell Biol. 2011; 31(2):199-210. PMC: 3272250. DOI: 10.1089/dna.2011.1283. View

17.

Qiu D, Kurosawa M, Lin Y, Inaba Y, Matsuba T, Kikuchi S . Overview of the epidemiology of pancreatic cancer focusing on the JACC Study. J Epidemiol. 2005; 15 Suppl 2:S157-67. PMC: 8639044. DOI: 10.2188/jea.15.s157. View

18.

Kuschel B, Auranen A, McBride S, Novik K, Antoniou A, Lipscombe J . Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet. 2002; 11(12):1399-407. DOI: 10.1093/hmg/11.12.1399. View

19.

Romanowicz-Makowska H, Smolarz B, Kulig A . Germline BRCA1 mutations and G/C polymorphism in the 5'-untranslated region of the RAD51 gene in Polish women with breast cancer. Pol J Pathol. 2006; 56(4):161-5. View

20.

Hu J, Mohrenweiser H, Bell D, Leadon S, Miller M . Symposium overview: genetic polymorphisms in DNA repair and cancer risk. Toxicol Appl Pharmacol. 2002; 185(1):64-73. DOI: 10.1006/taap.2002.9518. View